AURA
Aura Biosciences Inc
NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY
$7.05
+4.75% today
Updated 2026-04-30
Market cap
$432.06M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.76
Dividend yield
—
52W range
$4 – $8
Volume
0.3M
Aura Biosciences Inc (AURA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-73.50%
ROA
-40.10%
Debt/equity
0.11x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-24.20M | — | — | — |
| 2020 | $0.00 | $-22.21M | — | — | — |
| 2021 | $0.00 | $-35.25M | — | — | — |
| 2022 | $0.00 | $-58.76M | — | — | — |
| 2023 | $0.00 | $-76.41M | — | — | — |
| 2024 | $0.00 | $-86.92M | — | — | — |
| 2025 | $0.00 | $-106.19M | — | — | — |